Loading interface...

Atorlip ASP 20 Capsule

Manufactured byCIPLA LTD
ContainsAtorvastatin (20 mg) + Aspirin (75 mg)
Description
Atorlip ASP 20 Capsule is a combination medicine used for the treatment of patients suffering from dyslipidemia and cardiovascular diseases who are at an increased risk of complications such as a stroke, heart attack, peripheral vascular disease, etc. Patients are advised to maintain an appropriate exercise and diet regimen along with this medicine to get the best possible effect.

Side effects

Major & minor side effects for Atorlip ASP 20 Capsule

  • Abdominal pain
  • Heartburn
  • Constipation
  • Yellow colored eyes or skin
  • Skin rash
  • Irregular heart beat
  • Acid or sour stomach
  • Drowsiness
  • Irritability
  • Cough
  • Difficulty in swallowing
  • Diarrhea
  • Impaired liver function
  • Joint pain

Uses of Atorlip ASP 20 Capsule

What is it prescribed for?

  • Dyslipidemia with Atherosclerotic arterial disease
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine is cumulative and it may take up to 3 to 5 days to observe its effects.
  • How long do the effects of this medicine last?
    This medicine remains active in the body for up to 3 to 4 days after the onset of action.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.

Allergy

This medicine is not recommended for use in patients with a known allergy to aspirin, atorvastatin, or any other inactive ingredients present in the formulation.

Bleeding disorder

This medicine is not recommended for use in patients with a known history of peptic ulcer disease or any bleeding disorders due to the increased risk of worsening of the patient's condition.

Active liver disease

This medicine is not recommended for use in patients with a known history of active liver diseases or any abnormalities of liver function tests since it may worsen the patient's condition.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.
General warnings

Gastrointestinal bleeding

This medicine is not recommended for use in patients with gastrointestinal disorders such as peptic ulcer disease due to the increased risk of excessive bleeding. Replacement with a suitable alternative should be considered based on the clinical condition.

Asthma

This medicine is not recommended for use in patients with a known history of aspirin-sensitive asthma due to the increased risk of worsening the patient's condition.

Cognitive impairment

This medicine may cause forgetfulness, memory loss, confusion, etc. in some patients. These effects are reversible once the therapy is discontinued.

Muscle degradation in elderly

This medicine may cause muscle breakdown along with symptoms such as severe tiredness and weakness, especially in elderly patients. Close monitoring of the clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition.

Heavy alcohol consumption

This medicine may cause liver and kidney related problems if you consume alcohol very frequently in large quantities while on treatment with this medicine.

Missed Dose

The missed dose should be taken as soon as possible. It is advisable to skip the missed dose if it is already time for your next scheduled dose. Do not use extra medicine to make up for the missed dose

Overdose

Seek emergency medical treatment or contact the doctor in case of overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Nonsteroidal anti-inflammatory medicines

Azithromycin

ACE inhibitors

Erythromycin

Methotrexate

Clarithromycin

Disease interactions

Bleeding disorders

This medicine is not recommended for use in patients with an active bleeding disorder such as a peptic ulcer disease or intracranial bleeding since it may worsen the patient's condition. Replacement with a suitable alternative should be considered based on the clinical condition.

Liver Disease

This medicine is not recommended for use in patients with active liver diseases or abnormalities of liver function tests. In patients with a known history of liver diseases, this medicine should be used with caution due to the increased risk of serious adverse effects. Close monitoring of liver function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with suitable alternative may be required in some cases based on the clinical condition.

Rhabdomyolysis

This medicine is not recommended for use in patients with rhabdomyolysis since it may worsen the patient's condition. Replacement with a suitable alternative should be considered under your doctor's supervision.

Cognitive Impairment

This medicine should be used with caution in patients with cognitive impairment due to the increased risk of worsening of the patient's condition. Close monitoring of the patient for any changes in mood or behavior is recommended. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition.

Diabetes

This medicine should be used with caution in patients with diabetes mellitus due to the increased risk of altered blood glucose levels. Close monitoring of blood glucose levels is recommended for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition.
Food interactions
Consumption of grapefruit juice is not recommended during treatment with this medicine due to the increased risk of adverse effects such as dizziness, muscle pain, fever and chills, headache, swelling of hands and feet, vomiting, skin rash, etc.
Lab interactions
Information not available.
Take this medicine as instructed by the doctor. Do not take in larger amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
Atorvastatin reduces the level of cholesterol in the blood. Aspirin prevents abnormal blood clotting, relieves inflammation and swelling, and promotes a smooth flow of blood. Their combination is thus helpful in controlling dyslipidemia and reducing the risk of a heart attack or stroke.
Legal Status

Unknown

Unknown

Unknown

Unknown

Classification

Category

Statins, Antiplatelet agents

Schedule

Schedule H

[Internet]. CiplaMed. 2018 [cited 28 February 2018]. Available from:

https://ciplamed.com/content/atorlip-asp-capsules

[Internet]. 2017 [cited 30 May 2017]. Available from:

https://www.medicines.org.uk/emc/medicine/33364

Atorvastatin | C33H35FN2O5 - PubChem [Internet]. Pubchem.ncbi.nlm.nih.gov. 2017 [cited 23 February 2017]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/60823

[Internet]. 2017 [cited 23 February 2017]. Available from:

https://www.medicines.org.uk/emc/PIL.2498.latest.pdf
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 13 May 2019

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.